Leukemia, Lymphoblastic, Acute, T Cell
2 clinical trials · Condition
◉ Watch Leukemia, Lymphoblastic, Acute, T Cell
| Record | Firm | Date |
|---|---|---|
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) (NCT01186328) | Therapeutic Advances in Childhood Leukemia Consortium | 2010-08-24 |
| A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013) (NCT00100152) | Merck Sharp & Dohme LLC | 2005-02-01 |
Track Leukemia, Lymphoblastic, Acute, T Cell automatically
Every clearance here is in the API, with alerts when new ones post.